Laura Kemper is named as a lobbyist on federal disclosure filings for 95 clients through Jeffrey J. Kimbell & Associates, Inc. and 1 other registrant. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Medicare/Medicaid, Trade (domestic/foreign) and Agriculture.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| ARGENTA US HOLDINGS, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Animals |
| FLOREO INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
| GOSSAMER BIO, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
| CARA MEDICAL | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Medicare/Medicaid, Health Issues |
| ARCUTIS BIOTHERAPEUTICS, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Tariff (miscellaneous tariff bills), Health Issues |
| FLEX VASCULAR | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Medicare/Medicaid |
| HISTOSONICS, INC | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Medicare/Medicaid, Health Issues |
| PROVERUM MEDICAL | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
| CLEARFLOW, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Medicare/Medicaid |
| COALITION FOR AFFORDABLE PET CARE | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Animals, Labor Issues/Antitrust/Workplace, Consumer Issues/Safety/Products |
| MANNKIND CORPORATION | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Defense, Medicare/Medicaid, Health Issues |
| GAURDANT HEALTH | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
| ATARA BIOTHERAPEUTICS, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
| INDEMED | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
| MAGNOLIA MEDICAL TECHNOLOGIES, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Medicare/Medicaid |
| MAGNUS MEDICAL, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Medicare/Medicaid, Health Issues |
| COLOPLAST CORP | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Medicare/Medicaid |
| RAYNER INTRAOCULAR LENSES LIMITED | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Medicare/Medicaid |
| PAR HEALTH USA, LLC | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Trade (domestic/foreign), Health Issues |
| INDIVIOR INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
| AGIOS PHARMACEUTICALS, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
| NEUSPERA MEDICAL | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Medicare/Medicaid |
| GENETIX BIOTHERAPEUTICS | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
| OPUS GENETICS, INC | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
| ATEA PHARMACEUTICALS, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
| ACME UNITED CORPORATION | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Trade (domestic/foreign), Health Issues |
| AVALON HEALTHCARE SOLUTIONS | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
| JCYTE, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
| THE ALLERGY & ASTHMA ALLIANCE | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Medicare/Medicaid |
| MOBIA MEDICAL, INC (FKA MICROTRANSPONDER) | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
| CAPRICOR | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
| ONE CALL, CORP | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
| PHATHOM PHARMACEUTICALS | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
| RECOR MEDICAL | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Medicare/Medicaid, Health Issues |
| SUMMIT BEHAVIORAL HEALTHCARE | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
| ALEXION PHARMACEUTICALS | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Medicare/Medicaid, Health Issues |
| INSMED, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Medicare/Medicaid, Health Issues |
| HARROW INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Medicare/Medicaid, Health Issues |
| KENDAL NUTRICARE LTD | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Agriculture, Trade (domestic/foreign) |
| BIOTISSUE | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Medicare/Medicaid |
| SPARC | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
| NEUROTECH PHARMACEUTICALS | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
| AMGEN INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
| ILLUMINA, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues, Budget/Appropriations |
| WE WORK FOR HEALTH | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Medicare/Medicaid |
| MOMENTOUS | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Defense |
| COLLEGIUM PHARMACEUTICAL | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
| PHARMING HEALTHCARE, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
| SUPERNUS PHARMACEUTICALS INC | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Medicare/Medicaid, Health Issues |
| MEDICAL DEVICE MANUFACTURERS ASSOCIATION | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
| ORGANON & CO. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Medicare/Medicaid, Health Issues |
| STERIS CORPORATION | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
| GILEAD SCIENCES, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
| BROOKDALE SENIOR LIVING INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues, Housing |
| CATALYST PHARMACEUTICALS | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
| HARMONY BIOSCIENCES, LLC | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
| ORCHARD THERAPEUTICS NORTH AMERICA | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Medicare/Medicaid, Health Issues, Pharmacy |
| ARDELYX, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Medicare/Medicaid, Health Issues |
| INSTITUTE FOR GENE THERAPIES | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Medicare/Medicaid, Health Issues |
| GENUS LIFESCIENCES | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2026 | Health Issues |
Showing the 60 most recent of 95 engagements.
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 78 | 1 |
| 2025 | 66 | 2 |
| Year | Items | Total |
|---|---|---|
| 2026 | 3 | $4K |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Laura Kemper. See the Capitol Clarity rankings and method.